From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.
We’ve compiled a list of our readers’ top 10 articles for 2016.Â
Sphenopalatine Ganglion Block for Migraine?
The SPG is a promising target for migraine treatment, but robust evidence of efficacy for routine use of noninvasive deviceâmediated SPG blockade is needed.
Interesting Neuro: Staging Alzheimer & TBI Findings.
Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.
Interesting Neuro: Parkinson Rates & Zika News.
Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.
Interesting Neuro: Alzheimer & Parkinson Insights.
Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.
Botulinum Toxin: Guideline Updates.
Two authors of the updated AAN guidelines for treatment with botulinum neurotoxin discussed their findings and potential avenues of further research.
Cannabis and the Corpus Callosum.
Is there an association between high potency cannabis as well as frequency of use and damage to the corpus callosum?
Interesting Neuro: Migraine Drugs & Stroke Risks.
Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.
Interesting Neuro: Epilepsy Updates & Autism Risks.
Our Dec. news & research list includes groundbreaking research from AES 2015 as well as a few potential neurodegeneration biomarkers.
Migraine Preventative Butterbur Has Safety Concerns.
Despite butterbur’s potential efficacy, doubts are increasing about its long-term safety given of the risk of liver damage and the lack of an actively regulated preparation.